Company Overview - Tongling Jieya Biotechnology Co., Ltd. specializes in the research, production, and sales of wet wipes, established in 1999 [1] - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021, and is steadily advancing its fundraising projects [1] Financial Performance - For the first three quarters of 2025, the company reported a revenue of CNY 565 million and a net profit of CNY 67.90 million [2][3] - The growth in performance is attributed to an increase in orders from foreign clients, the realization of business model efficiencies, and continuous optimization of product structure [3] Strategic Initiatives - The company plans to deepen cooperation with international brand clients and is focused on the construction of a factory in the United States to explore new market opportunities [3] - The establishment of the U.S. factory is a strategic decision to optimize supply chain layout and better serve international core customers, enhancing the company's resilience against complex international trade environments [3] Competitive Advantages - The company has developed significant core competitive advantages in technology research and development, production processes, quality control, customer resources, and product variety through years of focused development in the wet wipes market [3] Operational Strategies - To address high labor costs in the U.S., the company will implement automated production lines and optimize management processes to improve operational efficiency and cost structure [3] - A pricing adjustment mechanism is in place to respond to fluctuations in raw material prices and exchange rates [4] Market Positioning - The company is accelerating its global business layout, with expectations that the proportion of foreign sales will exceed 50% this year based on current order conditions [4] - The cosmetics business primarily focuses on providing OEM services for international brand clients while actively expanding domestic customer orders [4] Future Outlook - The company is optimistic about achieving its equity incentive goals for 2025, based on the performance in the first three quarters of the year [4] - Continuous efforts are being made to ensure the smooth progress of fundraising projects, with updates available through company announcements [4]
洁雅股份(301108) - 2025年10月29日 投资者关系活动记录表